BP004830: Human DR6/TNFRSF21 Protein with the C-His Tag
Source: The recombinant Human DR6/TNFRSF21 Protein, (amino acids Gln42-His349) fused with a His tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human DR6 protein with the C-His tag at 0.5 ug/ml (100 ul/well) on the plate. Dose response curve for the recombinant Anti-DR6 Antibody protein with the C-hFc tag with the EC50 of 8.7 ng/ml determined by ELISA.
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP000440-HIV-105: Recombinant HIV-1 TAT Clade-A
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.
Applications: WB, SDS Page, Reacts with Mouse anti-Tat antibodies.BP000440-HIV-116: Recombinant HIV-1 TAT Clade-C
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-1 infected individuals.
Purity > 90%, by SDS-PAGE.
Applications: Recognized by anti-Tat (HIV-1) polyclonal antibody, Reacts with anti-Tat antibodies from human, monkey, rabbit and mouse serum.BP000440-HIV-128: Recombinant HIV-1 TAT, Biotin Labeled
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-1 infected individuals.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: WB, ELISA.BP000440-HIV-129: Recombinant HIV-1 TAT Clade-B
Source: E. coli-derived.
Purity > 90%, by HPLC and SDS-PAGE.
Applications: Recognized by anti-Tat (HIV-1) polyclonal antibody, Reacts with anti-Tat antibodies from human, monkey, rabbit and mouse serum.BP000440-HIV-136: Recombinant HIV-1 TAT Cys22
Source: E. coli-derived.
Specificity: Immunoreactive with all sera of HIV-1 infected individuals.
Purity > 90%, by SDS-PAGE.
Applications: Recognized by anti-Tat (HIV-1) polyclonal antibody, Reacts with anti-Tat antibodies from human, monkey, rabbit and mouse serum.BP000440-HIV-157: Recombinant HIV-1 TAT Clade-D
Source: E. coli-derived.
Purity > 90%, by SDS-PAGE.
Applications: WB, SDS Page, Reacts with Mouse anti-Tat antibodies.